|
Bal Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
143.48 Cr.
|
P/BV
|
1.79
|
Book Value (Rs.)
|
50.32
|
|
52 Week High/Low (Rs.)
|
111/60
|
FV/ML
|
10/1
|
P/E(X)
|
22.70
|
|
Bookclosure
|
25/09/2025
|
EPS (Rs.)
|
3.97
|
Div Yield (%)
|
1.33
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 3.95 | 4.54 | 4.94 | 1.67 | 3.79 |
| Diluted EPS (Rs.) | 3.95 | 4.54 | 4.96 | 1.68 | 3.79 |
| Cash EPS (Rs.) | 10.93 | 10.68 | 11.08 | 7.49 | 9.95 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 51.65 | 48.63 | 43.82 | 40.60 | 39.46 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 51.65 | 48.63 | 43.82 | 40.60 | 39.46 |
| Revenue From Operations / Share (Rs.) | 195.76 | 190.37 | 214.64 | 193.89 | 189.72 |
| PBDIT / Share (Rs.) | 21.25 | 19.95 | 21.75 | 16.61 | 19.31 |
| PBIT / Share (Rs.) | 14.29 | 13.81 | 15.38 | 10.79 | 13.21 |
| PBT / Share (Rs.) | 3.73 | 3.23 | 5.72 | 3.03 | 6.20 |
| Net Profit / Share (Rs.) | 3.97 | 4.54 | 4.71 | 1.67 | 3.85 |
| NP After MI And SOA / Share (Rs.) | 3.97 | 4.53 | 4.68 | 1.64 | 3.79 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 10.85 | 10.47 | 10.13 | 8.56 | 10.18 |
| PBIT Margin (%) | 7.30 | 7.25 | 7.16 | 5.56 | 6.96 |
| PBT Margin (%) | 1.90 | 1.69 | 2.66 | 1.56 | 3.26 |
| Net Profit Margin (%) | 2.02 | 2.38 | 2.19 | 0.86 | 2.02 |
| NP After MI And SOA Margin (%) | 2.02 | 2.38 | 2.17 | 0.84 | 1.99 |
| Return on Networth / Equity (%) | 7.68 | 9.32 | 10.66 | 4.03 | 9.57 |
| Return on Capital Employeed (%) | 18.01 | 18.92 | 20.86 | 16.30 | 20.64 |
| Return On Assets (%) | 1.68 | 2.14 | 2.31 | 0.82 | 2.15 |
| Long Term Debt / Equity (X) | 0.38 | 0.40 | 0.52 | 0.47 | 0.46 |
| Total Debt / Equity (X) | 1.94 | 1.94 | 2.01 | 2.05 | 1.67 |
| Asset Turnover Ratio (%) | 0.87 | 0.92 | 1.07 | 1.06 | 1.12 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.05 | 1.07 | 1.15 | 1.09 | 1.11 |
| Quick Ratio (X) | 0.58 | 0.60 | 0.72 | 0.62 | 0.66 |
| Inventory Turnover Ratio (X) | 2.84 | 3.18 | 1.95 | 2.08 | 2.43 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 26.47 | 21.22 | 60.55 | 26.41 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 11.24 | 8.98 | 13.30 | 10.11 |
| Earning Retention Ratio (%) | 0.00 | 73.53 | 78.78 | 39.45 | 73.59 |
| Cash Earning Retention Ratio (%) | 0.00 | 88.76 | 91.02 | 86.70 | 89.89 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 2.01 | 1.88 | 2.25 | 2.14 | 2.75 |
| Interest Coverage Ratio (Post Tax) (%) | 1.38 | 1.43 | 1.49 | 1.21 | 1.55 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 251.82 | 274.72 | 270.49 | 228.31 | 252.09 |
| EV / Net Operating Revenue (X) | 0.80 | 0.90 | 0.79 | 0.75 | 0.89 |
| EV / EBITDA (X) | 7.44 | 8.65 | 7.87 | 8.76 | 8.81 |
| MarketCap / Net Operating Revenue (X) | 0.30 | 0.43 | 0.42 | 0.34 | 0.56 |
| Retention Ratios (%) | 0.00 | 73.52 | 78.77 | 39.44 | 73.58 |
| Price / BV (X) | 1.16 | 1.71 | 2.08 | 1.65 | 2.73 |
| Price / Net Operating Revenue (X) | 0.30 | 0.43 | 0.42 | 0.34 | 0.56 |
| EarningsYield | 0.06 | 0.05 | 0.05 | 0.02 | 0.03 |
